Akademska digitalna zbirka SLovenije - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources SI consortium. For full access, REGISTER.

1 2
hits: 17
1.
  • Nivolumab-Induced Sarcoid-L... Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma
    Danlos, François-Xavier, MD; Pagès, Cécile, MD; Baroudjian, Barouyr, MD ... Chest, 05/2016, Volume: 149, Issue: 5
    Journal Article
    Peer reviewed
    Open access

    To our knowledge, we report the first case of sarcoid-like granulomatous reaction induced by nivolumab, a fully human IgG4 anti-programmed death 1 (PD-1) immune checkpoint inhibitor antibody. A ...
Full text
Available for: NUK, UL

PDF
2.
  • Syringotropic mycosis fungo... Syringotropic mycosis fungoides: Clinical and histologic features, response to treatment, and outcome in 19 patients
    de Masson, Adèle, MD; Battistella, Maxime, MD; Vignon-Pennamen, Marie-Dominique, MD ... Journal of the American Academy of Dermatology, 11/2014, Volume: 71, Issue: 5
    Journal Article
    Peer reviewed

    Background A rare variant of mycosis fungoides (MF), syringotropic MF (STMF) is characterized by a particular tropism of the lymphocytic infiltrate for the eccrine structures, and included in the ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
3.
  • Remitting seronegative symm... Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by Nivolumab
    Gauci, Marie-Léa, MD; Baroudjian, Barouyr, MD; Laly, Pauline, MD ... Seminars in arthritis and rheumatism, 10/2017, Volume: 47, Issue: 2
    Journal Article
    Peer reviewed

    Abstract PD-1 inhibitors have revolutionized the treatment of advanced melanoma but are responsible for immune-related toxicity. We report a case of remitting seronegative symetrical synovitis with ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK, ZRSKP
4.
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
5.
  • Infliximab for severe hidra... Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients
    Fardet, Laurence, MD; Dupuy, Alain, MD; Kerob, Delphine, MD ... Journal of the American Academy of Dermatology, 04/2007, Volume: 56, Issue: 4
    Journal Article
    Peer reviewed

    Background Hidradenitis suppurativa (HS) is a chronic and debilitating disorder. Despite its significant prevalence, few reports of therapeutic studies are available. Recent case studies have ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
6.
  • Imiquimod 5% cream for trea... Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients
    Célestin Schartz, Noël Emile, MD, PhD; Chevret, Sylvie, MD, PhD; Paz, Carolina, MD ... Journal of the American Academy of Dermatology, 04/2008, Volume: 58, Issue: 4
    Journal Article
    Peer reviewed

    Background Kaposi's sarcoma (KS), a virus-associated neoplasm, can be treated locally or systemically with interferon alfa. Therefore, imiquimod, an immune response modifier able to induce ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
7.
  • Incidence and risk factors ... Incidence and risk factors for corticosteroid-induced lipodystrophy: A prospective study
    Fardet, Laurence, MD; Cabane, Jean, MD; Lebbé, Céleste, MD, PhD ... Journal of the American Academy of Dermatology, 10/2007, Volume: 57, Issue: 4
    Journal Article
    Peer reviewed

    Background Very few studies have focused on fat redistribution induced by corticosteroids. Objective To establish the incidence and risk factors of facial (“moon face”) and cervical (“buffalo hump”) ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
8.
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
9.
  • Avelumab in patients with c... Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
    Kaufman, Howard L, Prof; Russell, Jeffery, MD; Hamid, Omid, MD ... The lancet oncology, 10/2016, Volume: 17, Issue: 10
    Journal Article
    Peer reviewed
    Open access

    Summary Background Merkel cell carcinoma is a rare, aggressive skin cancer with poor prognosis in patients with advanced disease. Current standard care uses various cytotoxic chemotherapy regimens, ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK

PDF
10.
  • Adjuvant ipilimumab versus ... Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
    Eggermont, Alexander M M, Prof; Chiarion-Sileni, Vanna, MD; Grob, Jean-Jacques, Prof ... The lancet oncology, 05/2015, Volume: 16, Issue: 5
    Journal Article
    Peer reviewed

    Summary Background Ipilimumab is an approved treatment for patients with advanced melanoma. We aimed to assess ipilimumab as adjuvant therapy for patients with completely resected stage III melanoma ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPUK
1 2
hits: 17

Load filters